Literature DB >> 17874652

Imaging of penile neoplasm.

Ajay K Singh1, Pedro Gonzalez-Torrez, Rathachai Kaewlai, Shahin Tabatabaei, Mukesh G Harisinghani.   

Abstract

Penile malignancies are rare, accounting for less than 1% of all male malignancy in the United States. The diagnosis can be very devastating psychologically to patients and often presents a challenge for physicians to accurately diagnose and treat these neoplasms. Clinical examination is known to have certain limitations and cross-sectional imaging techniques are increasingly utilized. Knowledge in imaging characteristics of the normal anatomy of the penis, vascular supply, lymphatic drainage, and pathology of penile malignancy is essential for an accurate staging. In this article, normal anatomy of the penis is briefly discussed and is followed by a review of multiple imaging approaches for characterization of the primary tumor and nodal staging.

Entities:  

Mesh:

Year:  2007        PMID: 17874652     DOI: 10.1053/j.sult.2007.05.005

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  3 in total

1.  Priapism secondary to penile metastasis of rectal cancer.

Authors:  Ji Chan Park; Wook Hyun Lee; Min Kyu Kang; Suk Young Park
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

Review 2.  Metastatic tumors of the penis: a report of 8 cases and review of the literature.

Authors:  Ke Zhang; Jun Da; Hai-Jun Yao; Da-Chao Zheng; Zhi-Kang Cai; Yue-Qing Jiang; Ming-Xi Xu; Zhong Wang
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

3.  External validation of nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes.

Authors:  Carlos Vaz de Melo Maciel; Roberto Dias Machado; Mariana Andozia Morini; Pablo Aloisio Lima Mattos; Ricardo Dos Reis; Rodolfo Borges Dos Reis; Gustavo Cardoso Guimarães; Isabela Werneck da Cunha; Eliney Ferreira Faria
Journal:  Int Braz J Urol       Date:  2019 Jul-Aug       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.